CN102660295A - Fluorine-containing azacyclic liquid crystal compound, synthetic method thereof and application thereof - Google Patents

Fluorine-containing azacyclic liquid crystal compound, synthetic method thereof and application thereof Download PDF

Info

Publication number
CN102660295A
CN102660295A CN2012101054635A CN201210105463A CN102660295A CN 102660295 A CN102660295 A CN 102660295A CN 2012101054635 A CN2012101054635 A CN 2012101054635A CN 201210105463 A CN201210105463 A CN 201210105463A CN 102660295 A CN102660295 A CN 102660295A
Authority
CN
China
Prior art keywords
fluorine
formula
compound
containing nitrogen
liquid crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101054635A
Other languages
Chinese (zh)
Inventor
曾卓
刘培炼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China Normal University
Original Assignee
South China Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China Normal University filed Critical South China Normal University
Priority to CN2012101054635A priority Critical patent/CN102660295A/en
Publication of CN102660295A publication Critical patent/CN102660295A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses a fluorine-containing azacyclic liquid crystal compound. The compound has a structure represented by formula I. A method for preparing the compound comprises the following steps: 1, mixing 2,2,3,3-tetrafluoro-1,4-butylene glycol with pyridine, adding trifluoromethanesulfonic anhydride, and reacting to obtain 2,2,3,3-tetrafluoro-1,4-butylene trifluoromethanesulfonate; 2, reacting a compound with the structure represented by formula V with 2,2,3,3-tetrafluoro-1,4-butylene trifluoromethanesulfonate to obtain a compound with the structure represented by formula III; 3, reacting the compound with the structure represented by the formula III with sodium t-butoxide to obtain a compound with the structure represented by formula IV; and 4, reacting a compound with the structure represented by formula II with the compound with the structure represented by the formula IV to obtain the fluorine-containing azacyclic liquid crystal compound with the structure represented by the formula I. The synthetic method of the fluorine-containing azacyclic liquid crystal compound of the invention has the advantages of simplicity, easy implementation, and high yield; the obtained fluorine-containing azacyclic liquid crystal compound has a wide mesomorphic phase temperature and a low melting point; and the mesomorphic phase transition temperature can be adjusted through adjusting the alkyl chain length and the fluorine content.

Description

A kind of fluorine-containing nitrogen heterocyclic liquid crystalline cpd and compound method and application
Technical field
The invention belongs to the liquid crystal material field, be specifically related to a kind of fluorine-containing nitrogen heterocyclic liquid crystalline cpd compound method and application.
Background technology
In recent decades, the fast development in liquid crystal material field has brought the great change of liquid-crystal display industry, and liquid-crystal display because its light weight, volume and power consumption are little, becomes one of leading product of modern displays as important information electronic product.And fluoro liquid crystals has that viscosity is low, resistivity is high, response speed is very fast, specific inductivity is than advantages such as height, is fit to very much the liquid-crystal display that TFT drives.The fluorine liquid crystalline cpd can reduce fusing point, suppresses or the elimination smectic phase, can widen nematic temperature range, increases specific inductivity.Fluorinated liquid crystal has high voltage retention, and not with temperature variation, is the liquid crystal material that is applicable to the TFT mode.
Liquid-crystal display requirement driving voltage is low, energy input is little, thus need to use the liquid crystal material of low threshold voltage, and such liquid crystal material necessarily requires high dielectric anisotropy.In recent years; People pass through molecule design method; In liquid crystal molecule, introduce the dielectric anisotropy that a plurality of polarity fluorine atoms improve molecule; The liquid crystal monomer of the high dielectric anisotropy of institute's synthetic mainly can be divided into to phenyl ring side direction, end and bridge chain introduces fluorine atom, through increasing molecular polarity, thereby effectively increases the dielectric anisotropy of molecule.
Liquid crystal is widely used in liquid-crystal display from being found to, and has experienced the course in more than 100 year.Liquid crystal material plays crucial effect in the evolution of liquid crystal display device, along with the raising of lcd technology level, to the demands for higher performance of liquid crystal material.Fluorinated liquid crystal is low with its good properties such as viscosity, response speed is fast, proper dielectric constant etc., occupies the critical role of liquid crystal display material, has vast potential for future development.
Summary of the invention
For the shortcoming and deficiency that overcome prior art, primary and foremost purpose of the present invention is to provide a kind of fluorine-containing nitrogen heterocyclic liquid crystalline cpd.
Another object of the present invention is to provide the preparation method of above-mentioned fluorine-containing nitrogen heterocyclic liquid crystalline cpd.
A purpose more of the present invention is to provide the purposes of above-mentioned fluorine-containing nitrogen heterocyclic liquid crystalline cpd.
The object of the invention is realized through following technical proposals:
A kind of fluorine-containing nitrogen heterocyclic liquid crystalline cpd has suc as formula the structure shown in the I:
Figure BDA0000152159940000021
Wherein, n is the natural number between the 0-10, and m is 1 or 2, R 1Be H, Cl, F, Br or CN, R 2Be H, Cl, F, Br or CN, X does
Figure BDA0000152159940000022
Preferably, n is 3 or 5, R 1=R 2=H.
The compound method of above-mentioned fluorine-containing nitrogen heterocyclic liquid crystalline cpd may further comprise the steps:
(1) get 2,2,3,3-tetrafluoro-1,4-butyleneglycol and pyridine are with mol ratio 1: (1.5-2.5) mix, add CH 2Cl 2And stir, adding trifluoromethanesulfanhydride anhydride again, stirring reaction 10 hours obtains product trifluoromethanesulfonic acid 2,2,3,3-tetrafluoro-1,4-fourth diester after reaction finishes; Following reaction takes place in this process:
Figure BDA0000152159940000023
(2) compound shown in the modus ponens V and trifluoromethanesulfonic acid 2,2,3,3-tetrafluoro-1,4-fourth diester mixes with mol ratio at 1: 1, adds dissolve with ethanol, and oil bath reflux 12 hours obtains the compound shown in the formula III after reaction finishes; Following reaction takes place in this process:
(3) compound shown in the modus ponens III and sodium tert-butoxide are with mol ratio 1: (4-8) mix, add DMSO 99.8MIN. as solvent, 60-100 ℃ of reaction 12 hours down obtains the compound shown in the formula IV after reaction finishes; Following reaction takes place in this process:
Figure BDA0000152159940000031
(4) compound shown in the formula II is mixed with mol ratio with the compound shown in formula III or the formula IV at 1: 1; Add N again; N '-NSC 57182 (DCC) and 4-Dimethylamino pyridine (DMAP); As solvent, reflux 12 hours obtains suc as formula the fluorine-containing nitrogen heterocyclic liquid crystalline cpd shown in the I after reaction finishes with trichloromethane; Following reaction takes place in this process:
Figure BDA0000152159940000032
Among the described formula II, n is the natural number between the 0-10, and n preferred 3 or 5; M is 1 or 2.
Among described formula III-V, R 1Be H, Cl, F, Br or CN, R 2Be H, Cl, F, Br or CN, X does
Figure BDA0000152159940000033
Preferably, R 1=R 2=H.
The described trifluoromethanesulfanhydride anhydride of step (1) and 2,2,3,3-tetrafluoro-1, the mol ratio of 4-butyleneglycol is 2: 1;
After the said reaction of step (1) finishes,, remove CH with organic layer washing, drying 2Cl 2, obtain the product trifluoromethanesulfonic acid 2,2,3 of white powder, 3-tetrafluoro-1,4-fourth diester solid; Described is water, saturated common salt water washing successively with the organic layer washing; Described drying is to use anhydrous Na 2SO 4Dry;
After the said reaction of step (2) finishes, remove ethanol, add CH 2Cl 2, the washing organic layer, drying obtains the compound shown in the formula III with petrol ether/ethyl acetate mixed solvent column chromatography at last; Described washing organic layer is water, saturated common salt water washing successively; Described drying is to use anhydrous MgSO 4Dry; In the described petrol ether/ethyl acetate mixed solvent, the volume ratio of sherwood oil and ETHYLE ACETATE is 20: 1;
After the said reaction of step (3) finishes, add CH 2Cl 2, the washing organic layer, drying obtains the compound shown in the formula IV with petrol ether/ethyl acetate mixed solvent column chromatography then; Described washing organic layer is water, saturated common salt water washing successively; Described drying is to use anhydrous MgSO 4Dry; In the described petrol ether/ethyl acetate mixed solvent, the volume ratio of sherwood oil and ETHYLE ACETATE is 30: 1;
The mol ratio of compound shown in the said formula II of step (4) and DCC, DMAP is 1: 1: 0.05;
After the said reaction of step (4) finishes, obtain fluorine-containing nitrogen heterocyclic liquid crystalline cpd with sherwood oil/trichloromethane mixed solvent column chromatography; Described N, N '-NSC 57182 (DCC) is as dewatering agent; Described 4-Dimethylamino pyridine (DMAP) is as catalyzer; In described sherwood oil/trichloromethane mixed solvent, the volume ratio of sherwood oil and trichloromethane is 5: (2-3).
Above-mentioned fluorine-containing nitrogen heterocyclic liquid crystalline cpd can be used as liquid crystal display material.
The present invention has following advantage and effect with respect to prior art:
1, the compound method of fluorine-containing nitrogen heterocyclic liquid crystalline cpd of the present invention is simple, and yield is high.
2, fluorine-containing nitrogen heterocyclic liquid crystalline cpd of the present invention has wide mesomorphous phase temperature, and lower fusing point is arranged.
3, fluorine-containing nitrogen heterocyclic liquid crystalline cpd of the present invention can be regulated the mesomorphous phase transition temperature through length and the fluorine content of regulating alkyl chain.
Description of drawings
Fig. 1 is that the poor formula scanning calorimeter of the embodiment of the invention 1 product 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(1-hydrogen-2,3-difluoro pyrroles) phenyl ester is analyzed collection of illustrative plates (DSC collection of illustrative plates).
Fig. 2 is the polarizing microscope collection of illustrative plates (POM collection of illustrative plates) of the embodiment of the invention 1 product 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(1-hydrogen-2,3-difluoro pyrroles) phenyl ester; Wherein, a is this compound at 164 ℃ POM collection of illustrative plates, and b is this compound at 265 ℃ POM collection of illustrative plates, and c is this compound at 280 ℃ POM collection of illustrative plates.
Embodiment
Below in conjunction with embodiment and accompanying drawing the present invention is described in further detail, but embodiment of the present invention is not limited thereto.
Embodiment 1
Synthesizing of 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(1-H-2,3-difluoro pyrroles) phenyl ester, may further comprise the steps:
(1) trifluoromethanesulfonic acid 2,2,3,3-tetrafluoro-1,4-fourth diester synthetic
With 2,2,3,3-tetrafluoro-1, the 4-butyleneglycol (3.24g, 20mmol) and pyridine (3.96g 50mmol) places round-bottomed flask, adds 100ml CH 2Cl 2And after stirring 10 minutes, add then trifluoromethanesulfanhydride anhydride (11g, 40mmol).Add the back and stirred 10 hours, water, saturated common salt water washing organic layer successively then, anhydrous Na 2SO 4Drying is removed CH 2Cl 2, obtain white powder trifluoromethanesulfonic acid 2,2,3,3-tetrafluoro-1,4-fourth diester, productive rate 90%.
(2) 4-(3,3,4,4-tetrafluoro tetramethyleneimine) phenol is synthetic
Get PARA AMINOPHENOL (0.55g 5mmol) in round-bottomed flask, adds trifluoromethanesulfonic acid 2,2,3,3-tetrafluoro-1, (2.13g 5mmol), adds dissolve with ethanol to 4-fourth diester, loads onto reflux condensing tube reflux 12 hours in oil bath.Remove ethanol after reaction finishes, add CH 2Cl 2, water, saturated common salt water washing organic layer successively then, anhydrous MgSO 4Drying, (V: V=20: 1) the mixed solvent column chromatography obtains lurid product 4-(3,3,4,4-tetrafluoro tetramethyleneimine) phenol, productive rate 72% to use petrol ether/ethyl acetate at last.
Structural characterization data to product are: 1H NMR (CDCl 3) δ (ppm): 6.81 (d, J=8.6Hz, 2H), 6.44 (d, J=8.8Hz, 2H), 3.74 (t, J=10.4Hz, 4H). 19F NMR (CDCl 3) δ: (ppm) :-121.90-121.97 (m, 4F) .MS (ESI) m/z:234.91 (M +) .Anal.Calcd (%) for:C10H9F4NO (235.18): C, 51.07; H, 3.86; N, 5.96.Found:C, 51.06; H, 3.83; N, 5.97. infer that in view of the above the structure of product is following, are 4-(3,3,4,4-tetrafluoro tetramethyleneimine) phenol.
Figure BDA0000152159940000051
(3) 4-(1H-3,4-difluoro pyrroles) phenol is synthetic
(0.47g, 2mmol) in round-bottomed flask, (0.64g 16mmol), makes solvent with DMSO 99.8MIN., and 100 ℃ were reacted 12 hours down to add sodium tert-butoxide to get 4-(2,2,3,3-tetrafluoro tetramethyleneimine) phenol.After finishing, reaction adds CH 2Cl 2, water, saturated common salt water washing organic layer successively then, anhydrous MgSO 4Drying, (V: V=30: 1) the mixed solvent column chromatography obtains lurid product 4-(1H-3,4-difluoro pyrroles) phenol, productive rate 85% to use petrol ether/ethyl acetate at last.
Structural characterization data to product are: 1H NMR (CDCl 3) δ (ppm): 7.14 (d, J=8.7Hz, 2H), 6.87 (d, J=8.7Hz, 2H), 6.61 (s, 2H), 4.89 (s, 1H). 19F NMR (CDCl 3) δ (ppm) :-178.29 (s, 2F) .MS (ESI) m/z:194.27 (M ++ 1) .Anal.Calcd (%) for:C10H7F2NO (195.17): C, 61.54; H, 3.62; N, 7.18.Found:C, 61.55; H, 3.64; N, 7.16. infer that in view of the above the structure of product is following, are 4-(1H-3,4-difluoro pyrroles) phenol.
(4) fluorine-containing nitrogen heterocyclic liquid crystalline cpd 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(1H-3,4-difluoro pyrroles) phenyl ester is synthetic
(structure is
Figure BDA0000152159940000053
(0.25g in round-bottomed flask, to add 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid; 1mmol) and 4-(1H-3,4-difluoro pyrroles) phenol (0.2g, 1mmol); N; N '-NSC 57182 (DCC) (0.21g, 1mmol) and 4-Dimethylamino pyridine (DMAP) (0.006g, 0.05mmol); With trichloromethane as solvent, reflux 12 hours.After reaction finished, (V: V=5: 2) the mixed solvent column chromatography obtained fluorine-containing nitrogen heterocyclic liquid crystalline cpd 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(1H-3,4-difluoro pyrroles) phenyl ester, productive rate 83% with sherwood oil/trichloromethane.
Structural characterization data to product are: 1H NMR (CDCl 3) δ (ppm): 7.24 (d, J=8.7Hz, 2H), 7.10 (d, J=8.7Hz, 2H), 6.68 (s, 2H), 2.49-1.28 (m, 27H). 19F NMR (CDCl 3) δ (ppm) :-177.34 (s, 2F) .MS (ESI) m/z:452.10 (M ++ 23) .Anal.Calcd (%) for:C26H33F2NO2 (429.54): C, 72.70; H, 7.74; N, 3.26.Found:C, 72.34; H, 7.73; N, 3.29. infer that in view of the above the structure of product is following, are 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(1H-3,4-difluoro pyrroles) phenyl ester.
Figure BDA0000152159940000061
Embodiment 2
Synthesizing of 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(3,3,4,4-tetrafluoro pyrroles) phenyl ester, may further comprise the steps:
(1) trifluoromethanesulfonic acid 2,2,3,3-tetrafluoro-1,4-fourth diester synthetic
With embodiment 1 step (1);
(2) 4-(3,3,4,4-tetrafluoro pyrroles) phenol is synthetic
With embodiment 1 step (2);
(3) fluorine-containing nitrogen heterocyclic liquid crystalline cpd 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(3,3,4,4-tetrafluoro pyrroles) phenyl ester is synthetic
In round-bottomed flask, add 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid
Figure BDA0000152159940000062
(0.25g, 1mmol) and 4-(3,3; 4,4-tetrafluoro pyrroles) phenol (0.24g, 1mmol); N; N '-NSC 57182 (DCC) (0.21g, 1mmol) and 4-Dimethylamino pyridine (DMAP) (0.006g, 0.05mmol); With trichloromethane as solvent, reflux 12 hours.After reaction finished, (V: V=5: 3) the mixed solvent column chromatography obtained fluorine-containing nitrogen heterocyclic liquid crystalline cpd 4-(anti--4 '-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(3,3,4,4-tetrafluoro pyrroles) phenyl ester, productive rate 85% with sherwood oil/trichloromethane.
Structural characterization data to product are: 1H NMR (CDCl 3) δ (ppm): 6.99 (d, J=8.7Hz, 2H), 6.51 (d, J=8.8Hz, 2H), 3.86-3.75 (m, 4H), 2.46-0.85 (m, 27H). 19F NMR (CDCl 3) δ (ppm) :-122.65-122.72 (m, 4F) .MS (ESI) m/z:469.50 (M +) .Anal.Calcd (%) for:C26H35F4NO2 (469.56): C, 66.51; H, 7.51; N, 2.98.Found:C, 66.47; H, 7.46; N, 3.00. infer that in view of the above the structure of product is following, are 4-(anti--4 '-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(3,3,4,4-tetrafluoro pyrroles) phenyl ester.
Figure BDA0000152159940000071
Embodiment 3
Instead-and 4-n-propyl hexahydrobenzoic acid 4 '-(1H-3,4-difluoro pyrroles) phenyl ester synthetic, may further comprise the steps:
(1) trifluoromethanesulfonic acid 2,2,3,3-tetrafluoro-1,4-fourth diester synthetic
With embodiment 1 step (1);
(2) 4-(3,3,4,4-tetrafluoro pyrroles) phenol is synthetic
With embodiment 1 step (2);
(3) 4-(1H-3,4-difluoro pyrroles) phenol is synthetic
With embodiment 1 step (3);
(4) fluorine-containing nitrogen heterocyclic liquid crystalline cpd anti--4-n-propyl hexahydrobenzoic acid 4 '-(1H-3,4-difluoro pyrroles) phenyl ester synthetic
In round-bottomed flask, add anti--4-n-propyl hexahydrobenzoic acid
Figure BDA0000152159940000072
(0.17g; 1mmol) and 4-(1H-3,4-difluoro pyrroles) phenol (0.24g, 1mmol); N; N '-NSC 57182 (DCC) (0.21g, 1mmol) and 4-Dimethylamino pyridine (DMAP) (0.006g, 0.05mmol); With trichloromethane as solvent, reflux 12 hours.After reaction finishes, with sherwood oil/trichloromethane (V: V=5: 2) the mixed solvent column chromatography obtain fluorine-containing nitrogen heterocyclic liquid crystalline cpd instead-4-n-propyl hexahydrobenzoic acid 4 '-(1H-3,4-difluoro pyrroles) phenyl ester, productive rate 86%.
Structural characterization data to product are: 1H NMR (CDCl 3) δ (ppm): 7.24 (d, J=8.7Hz, 2H), 7.11 (d, J=8.8Hz, 2H), 6.68 (s, 2H), 2.48-0.90 (m, 17H). 19F NMR (CDCl 3) δ (ppm) :-177.34 (s, 2F) .MS (ESI) m/z:347.85 (M +) .Anal.Calcd (%) for:C20H23F2NO2 (347.4): C, 69.15; H, 6.67; N, 4.03.Found:C, 69.12; H, 6.65; N, 4.04. infer that in view of the above the structure of product is following, for instead-4-n-propyl hexahydrobenzoic acid 4 '-(1H-3,4-difluoro pyrroles) phenyl ester.
Figure BDA0000152159940000081
Embodiment 4
Product 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(1H-3,4-difluoro pyrroles) phenyl ester of embodiment 1 is tested its phase transition temperature with differential scanning calorimetric analysis appearance (DSC).
The result is as shown in Figure 1, and the temperature that is changed into mesomorphic phase by crystallization phases is 157.5 ℃, is 290.5 ℃ by liquid crystal phase transition for each temperature to phasic property liquid.
Embodiment 5
Product 4-(anti--4-n-propyl cyclohexyl) hexahydrobenzoic acid 4 '-(1H-3,4-difluoro pyrroles) phenyl ester of embodiment 1 is carried out the polarizing microscope sign.
The result is as shown in Figure 2, figure a, and b, c are respectively 164 ℃, 265 ℃, the polarizing microscope collection of illustrative plates under 280 ℃, collection of illustrative plates demonstrates the typical schlieren texture that nematic liquid crystal has.
The result of comprehensive embodiment 4-5 can find out that the product of embodiment 1 has wide mesomorphous phase TR.
Its DSC test result of the product of embodiment 2-3 and polarizing microscope characterization result and embodiment's 1 is approximate, shows that the product of embodiment 2-3 also has wide mesomorphous phase TR.
The foregoing description is a preferred implementation of the present invention; But embodiment of the present invention is not restricted to the described embodiments; Other any do not deviate from change, the modification done under spirit of the present invention and the principle, substitutes, combination, simplify; All should be the substitute mode of equivalence, be included within protection scope of the present invention.

Claims (10)

1. fluorine-containing nitrogen heterocyclic liquid crystalline cpd is characterized in that: have suc as formula the structure shown in the I:
Wherein, n is the natural number between the 0-10, and m is 1 or 2, R 1Be H, Cl, F, Br or CN, R 2Be H, Cl, F, Br or CN, X does
2. fluorine-containing nitrogen heterocyclic liquid crystalline cpd according to claim 1 is characterized in that: described n is 3 or 5, R 1=R 2=H.
3. the compound method of claim 1 or 2 described fluorine-containing nitrogen heterocyclic liquid crystalline cpds is characterized in that may further comprise the steps:
(1) get 2,2,3,3-tetrafluoro-1,4-butyleneglycol and pyridine are with mol ratio 1: (1.5-2.5) mix, add CH 2Cl 2And stir, adding trifluoromethanesulfanhydride anhydride again, stirring reaction 10 hours obtains product trifluoromethanesulfonic acid 2,2,3,3-tetrafluoro-1,4-fourth diester after reaction finishes;
(2) compound shown in the modus ponens V and trifluoromethanesulfonic acid 2,2,3,3-tetrafluoro-1,4-fourth diester mixes with mol ratio at 1: 1, adds dissolve with ethanol, and oil bath reflux 12 hours obtains the compound shown in the formula III after reaction finishes;
(3) compound shown in the modus ponens III and sodium tert-butoxide are with mol ratio 1: (4-8) mix, add DMSO 99.8MIN. as solvent, 60-100 ℃ of reaction 12 hours down obtains the compound shown in the formula IV after reaction finishes;
(4) compound shown in the formula II is mixed with mol ratio with the compound shown in formula III or the formula IV at 1: 1; Add N again; N '-NSC 57182 and 4-Dimethylamino pyridine; As solvent, reflux 12 hours obtains suc as formula the fluorine-containing nitrogen heterocyclic liquid crystalline cpd shown in the I after reaction finishes with trichloromethane;
The described trifluoromethanesulfanhydride anhydride of step (1) and 2,2,3,3-tetrafluoro-1, the mol ratio of 4-butyleneglycol is 2: 1;
Figure FDA0000152159930000013
Figure FDA0000152159930000021
Among the described formula II, n is the natural number between the 0-10, and m is 1 or 2;
Among described formula III-V, R 1Be H, Cl, F, Br or CN, R 2Be H, Cl, F, Br or CN, X does
Figure FDA0000152159930000022
4. the compound method of fluorine-containing nitrogen heterocyclic liquid crystalline cpd according to claim 3 is characterized in that:
Among the described formula II, n is 3 or 5;
Among described formula III-V, R 1=R 2=H.
5. the compound method of fluorine-containing nitrogen heterocyclic liquid crystalline cpd according to claim 3 is characterized in that: after the said reaction of step (1) finishes, with organic layer washing, drying, remove CH 2Cl 2, obtain trifluoromethanesulfonic acid 2,2,3,3-tetrafluoro-1,4-fourth diester.
6. the compound method of fluorine-containing nitrogen heterocyclic liquid crystalline cpd according to claim 3 is characterized in that: after the said reaction of step (2) finishes, remove ethanol, add CH 2Cl 2, the washing organic layer, drying obtains the compound shown in the formula III with petrol ether/ethyl acetate mixed solvent column chromatography at last.
7. the compound method of fluorine-containing nitrogen heterocyclic liquid crystalline cpd according to claim 3 is characterized in that: after the said reaction of step (3) finishes, add CH 2Cl 2, the washing organic layer, drying obtains the compound shown in the formula IV with petrol ether/ethyl acetate mixed solvent column chromatography then.
8. the compound method of fluorine-containing nitrogen heterocyclic liquid crystalline cpd according to claim 3 is characterized in that: compound and the N shown in the said formula II of step (4), the mol ratio of N '-NSC 57182,4-Dimethylamino pyridine is 1: 1: 0.05.
9. the compound method of fluorine-containing nitrogen heterocyclic liquid crystalline cpd according to claim 3 is characterized in that: after the said reaction of step (4) finishes, obtain fluorine-containing nitrogen heterocyclic liquid crystalline cpd with sherwood oil/trichloromethane mixed solvent column chromatography.
10. claim 1 or 2 application of described fluorine-containing nitrogen heterocyclic liquid crystalline cpd in liquid crystal display material.
CN2012101054635A 2012-04-11 2012-04-11 Fluorine-containing azacyclic liquid crystal compound, synthetic method thereof and application thereof Pending CN102660295A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101054635A CN102660295A (en) 2012-04-11 2012-04-11 Fluorine-containing azacyclic liquid crystal compound, synthetic method thereof and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101054635A CN102660295A (en) 2012-04-11 2012-04-11 Fluorine-containing azacyclic liquid crystal compound, synthetic method thereof and application thereof

Publications (1)

Publication Number Publication Date
CN102660295A true CN102660295A (en) 2012-09-12

Family

ID=46769879

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101054635A Pending CN102660295A (en) 2012-04-11 2012-04-11 Fluorine-containing azacyclic liquid crystal compound, synthetic method thereof and application thereof

Country Status (1)

Country Link
CN (1) CN102660295A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105062502A (en) * 2015-08-07 2015-11-18 华南师范大学 Liquid crystal compound containing five membered nitrogen-containing heterocycles, as well as synthesizing method and application thereof
CN108774536A (en) * 2018-05-22 2018-11-09 王红 A kind of preparation method of flexure type liquid crystal new material

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134895A (en) * 1975-06-18 1979-01-16 Ciba-Geigy Corporation Imidyl-benzenedicarboxylic acid derivatives
US5238602A (en) * 1984-07-16 1993-08-24 Hoffmann La Roche Inc. Liquid crystals
US5360577A (en) * 1991-09-26 1994-11-01 Hoffmann-La Roche Inc. Oxaxoline derivatives
JP2003277359A (en) * 2002-01-16 2003-10-02 Chisso Corp Liquid crystalline 3,4-substituted pyrrole
WO2003101449A2 (en) * 2002-06-04 2003-12-11 Pfizer Products Inc. Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
US20050224756A1 (en) * 2002-06-24 2005-10-13 Volker Reiffenrath 3,3,4,4-Tetrafluorocyclopentane compounds, used as components of liquid crystal media

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134895A (en) * 1975-06-18 1979-01-16 Ciba-Geigy Corporation Imidyl-benzenedicarboxylic acid derivatives
US5238602A (en) * 1984-07-16 1993-08-24 Hoffmann La Roche Inc. Liquid crystals
US5360577A (en) * 1991-09-26 1994-11-01 Hoffmann-La Roche Inc. Oxaxoline derivatives
JP2003277359A (en) * 2002-01-16 2003-10-02 Chisso Corp Liquid crystalline 3,4-substituted pyrrole
WO2003101449A2 (en) * 2002-06-04 2003-12-11 Pfizer Products Inc. Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
US20050224756A1 (en) * 2002-06-24 2005-10-13 Volker Reiffenrath 3,3,4,4-Tetrafluorocyclopentane compounds, used as components of liquid crystal media

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105062502A (en) * 2015-08-07 2015-11-18 华南师范大学 Liquid crystal compound containing five membered nitrogen-containing heterocycles, as well as synthesizing method and application thereof
CN108774536A (en) * 2018-05-22 2018-11-09 王红 A kind of preparation method of flexure type liquid crystal new material

Similar Documents

Publication Publication Date Title
TWI564371B (en) A liquid crystal compound containing a difluoromethoxy bridge bond, a composition and a use thereof
CN108251127A (en) Liquid crystal compound containing difluoromethoxy bridge bond and application thereof
US5399291A (en) Liquid crystal compounds having a fluoroether terminal portion
CN103602337B (en) Cyclohexane derivatives, preparation method thereof and applications thereof
CN103058886B (en) Poly-fluorine poly-cyanogen liquid crystal compound as well as preparation method and application thereof
TWI507386B (en) Cycloheptane derivative and preparation method and application thereof
CN104640832B (en) There is the compound and liquid-crystal composition thereof of fluoridizing naphthalene structure
CN104003964B (en) A kind of liquid-crystal compounds containing amylene oxide ring and application thereof
CN101768447B (en) Polyfluoric terphenyl liquid crystal compound and synthesis method and use thereof
CN105131971A (en) Liquid crystal compound with 2-fluorophenyl group and difluoro methyleneoxy group and preparing method and application thereof
CN103524394A (en) Synthetic method and application of fluorine-containing azacyclo-alkyne liquid crystal compound
CN102660295A (en) Fluorine-containing azacyclic liquid crystal compound, synthetic method thereof and application thereof
CN101338199A (en) Nematic phase liquid crystal composition
CN112980461A (en) Negative dielectric liquid crystal compound and preparation and application thereof
CN106083538A (en) A kind of compound, liquid-crystal composition and liquid crystal display
JP4963863B2 (en) Novel compound and liquid crystal composition containing the compound
CN109251136A (en) A kind of compound, liquid-crystal composition and display device
CN110938439B (en) High-polarity large-optical birefringence liquid crystal composition
JP4521738B2 (en) Benzothiazole compound, process for producing the same, liquid crystal composition, and liquid crystal element
CN110272746A (en) Liquid-crystal compounds and liquid-crystal composition containing it
CN103788039A (en) Liquid crystal compound containing tetrahydropyrane difluoro methoxy-linking group and preparation method and application thereof
JPS63284147A (en) Liquid crystal substance, its production and liquid crystal composition containing said substance
CN113493689B (en) Liquid crystal compound containing difluoromethoxy bridge bond and preparation method and application thereof
JP2010024157A (en) Diamantane compound
JP4753064B2 (en) Liquid crystal composition, display element and compound containing trifluoronaphthalene derivative.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120912